The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway
Cellular Signalling · 2023-07 · 107 · 110688
DOI: 10.1016/j.cellsig.2023.110688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2023-07. Verfasst von Lingling Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Chongqing University, Chongqing 400044, People's Republic of China. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chongqing Science and Technology Commission.
Abstract (Originalsprache)
Cancer stem cells (CSCs) play a central role in ovarian cancer (OC), understanding regulatory mechanisms governing their stemness is critical. Here, we report ISYNA1, the rate-limiting enzyme in myo-inositol biosynthesis, as a suppressor of OC regulating cancer stemness. We identified ISYNA1 as a differentially expressed gene in normal ovary and ovarian cancer tissues, as well as OC cells and OCSCs. Low ISYNA1 expression correlated with poor prognosis in OC patients. In addition, ISYNA1 was negatively correlated with cancer stem cell (CSC) markers, and ISYNA1-related pathways were enriched in Wnt, Notch, and other critical cancer pathways. ISYNA1 deficiency promoted OC cell growth, migration, and invasion ability in vitro and in vivo. Knockdown of ISYNA1 increased stemness of OC cells, including self-renewal, CSC markers expression, ALDH activity, and proportion of CD44+/CD117+ CSCs. Conversely, ectopic overexpression of ISYNA1 suppresses cell proliferation, migration, invasion and stemness of OC cells. Mechanistically, ISYNA1 inhibits OC stemness by regulating myo-inositol to suppress Notch1 signaling. In summary, these data provide evidence that ISYNA1 act as a tumor suppressor in OC and a regulator of stemness, providing insight into potentially targetable pathways for ovarian cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Chongqing University, Chongqing 400044, People's Republic of China.
- College of Bioengineering, Chongqing University, Chongqing 400044, People's Republic of China.
- Department of Gynecologic Oncology, Chongqing University Cancer Hospital, Chongqing 400030, People's Republic of China.
- Department of Gynecologic Oncology, Chongqing University Cancer Hospital, Chongqing 400030, People's Republic of China. Electronic address: michaellang2009@163.com.
- School of Medicine, Chongqing University, Chongqing 400044, People's Republic of China; Department of Gynecologic Oncology, Chongqing University Cancer Hospital, Chongqing 400030, People's Republic of China. Electronic…
Förderung
- Chongqing Science and Technology Commission
Zitieren
APA
Yang, L., Yang, M., Cui, C., Long, X., Li, Y., Dai, W., Lang, T., & Zhou, Q. (2023). The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway. Cellular Signalling, 107, 110688. https://doi.org/10.1016/j.cellsig.2023.110688
Vancouver
Yang L, Yang M, Cui C, Long X, Li Y, Dai W, et al. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway. Cellular Signalling. 2023;107:110688. doi:10.1016/j.cellsig.2023.110688
BibTeX
@article{Yang2023,
author = {Yang, Lingling and Yang, Muyao and Cui, Chenxi and Long, Xingtao and Li, Yunzhe and Dai, Weili and Lang, Tingyuan and Zhou, Qi},
title = {The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway},
journal = {Cellular Signalling},
year = {2023},
volume = {107},
pages = {110688},
doi = {10.1016/j.cellsig.2023.110688}
}
EUVIMED